Teh problem with single-pathway agonists is that you hit one receptor and the compensatory mechanisms kick in, limiting how much glucose control or weight reduction you actually get — this dual GIP/GLP-1 approach basically shuts down that escape route in research models.

It's got better affinity for GIP receptors than selective GLP-1 compounds while still keeping solid activity at the GLP-1 site, and that combination is what drives enhanced hyperglycemia reduction we see in the data.

White powder, >98% verified by HPLC, molecular weight comes in at 4813.45 g/mol with the CAS being 2023788-19-2. You'll need -20°C storage for long-term stability, and shelf life is over 2 years if you keep it cold — we usually have stock but confirm lead time (typically 2-4 weeks).
Most buyers go with gram quantities for multi-dose studies, but the 100mg vial is easier to reconstitute if you're doing smaller batches. Not suited for anything beyond research use — this isn't a compounded pharmacy product.

Also, the powder is hygroscopic so keep it sealed until you're ready to reconstitute; we've seen moisture degrade potency faster than tempearture shifts alone. COA is provided per batch, HPLC trace included.